Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Trial of Low Dose Radiation THerapy to Reduce Cerebral Amyloidosis in Early Alzheimer's Dementia

NCT02769000 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT02769000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02769000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Trial of Low Dose Radiation THerapy to Reduce Cerebral Amyloidosis in Early Alzheimer's Dementia
Lead sponsor
Virginia Commonwealth University
Phase
Not applicable
Overall status
Terminated
Start date
May 31, 2016
Completion date
March 15, 2019
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease